Moderate Complexity Nucleic Acid Amplification Tests (NAATS) for the diagnosis of Multi-drug Resistant Tuberculosis (MDR-TB) with isoniazid (INH) and rifampicin (RIF) resistance testing
Cycle 2 | Clinical Equipment and DevicesHTA Council Recommendation (as of 01 December 2025)
As a final recommendation, the HTA Council recommends moderate complexity NAATs for the diagnosis of MDR-TB with INH and RIF resistance testing, for financing of DOH and/or PhilHealth.
Relevant Information
- Status: With Final HTA Council Recommendation and SOH Decision
- Topic Assignment: Internal/ External Assessment
- Policy Question: Should moderate complexity NAATs for the diagnosis of MDR-TB with INH and RIF resistance testing be funded by DOH and/or PhilHealth?
- Secretary of Health Decision: Approved as of 29 April 2026
Evidence and Relevant Documents